Home / Clinical Laboratory / Controls / Control / Hematology Control XN Check™ Low Level / Normal Level / High Level 4 X 3 X 3 mL213499
Picture of Hematology Control XN Check™ Low Level / Normal Level / High Level 4 X 3 X 3 mL213499

Hematology Control XN Check™ Low Level / Normal Level / High Level 4 X 3 X 3 mL213499

Hematology-Control-XN-Check™-Low-Level--Normal-Level--High-Level-4-X-3-X-3-mL213499

SKU #

#841054

MPN #

213499

Brand

Sysmex America

Stock

In Stock

Quantity

100

Features

CONTROL, HEMATOLOGY XN CHECK

$317.48 USD

Attribute Name Attribute Value
McKesson # 841054
Manufacturer # 213499
Brand XN Check™
Manufacturer Sysmex America
Application Control
For Use With For XN-Series Analyzers
Levels Low Level / Normal Level / High Level
Storage Requirements Requires Refrigeration
Test Type Hematology
UNSPSC Code 41116122
Volume 4 X 3 X 3 mL

Similar Items

Underarm Crutches McKesson Aluminum Frame Tall Adult 350 lbs. Weight Capacity Push Button - Adjustment

One Size Fits Most White NonSterile Not Rated 8211

In Stock

PR/1 $9.76 USD

Underarm Crutches McKesson Aluminum Frame Tall Adult 350 lbs. Weight Capacity Push Button - Adjustment

One Size Fits Most White NonSterile Not Rated 8211

In Stock

PR/1 $9.76 USD

Underarm Crutches McKesson Aluminum Frame Tall Adult 350 lbs. Weight Capacity Push Button - Adjustment

One Size Fits Most White NonSterile Not Rated 8211

In Stock

PR/1 $9.76 USD

Underarm Crutches McKesson Aluminum Frame Tall Adult 350 lbs. Weight Capacity Push Button - Adjustment

One Size Fits Most White NonSterile Not Rated 8211

In Stock

PR/1 $9.76 USD

  • XN CHECK is a control blood designed specifically for the XN-Series that makes it possible to thoroughly check the analysers’ technical functions and reagent system
  • XN CHECK provides assay data for all diagnostic parameters: eight CBC parameters, WBC differential count, immature myeloid information, nucleated red blood cells and reticulocytes
  • It is non-reactive for hepatitis B surface antigen, hepatitis C virus (HCV) and HIV1/HIV2 anti-body using techniques specified by the FDA